Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Phase 1 Study of Dexanabinol in Patients With Advanced Solid Tumours

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2014 by e-Therapeutics PLC
Sponsor:
Information provided by (Responsible Party):
e-Therapeutics PLC
ClinicalTrials.gov Identifier:
NCT01489826
First received: December 7, 2011
Last updated: April 14, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)